p <0.001 CSHQ, sleep duration, mean ± SD: G1: 4.38 ± 1.02 G2: 4.82 ± 0.94 G3: 6.68 ± 1.16 G4: 6.40 ± 1.29 p <0.001 CSHQ, parasomnias, mean ± SD: G1: 8.92 ± 1.38 G2: 9.35 ± 1.78 G3: 9.82 ± 2.25 G4: 9.16 ± 1.53 p =0.82 CSHQ, daytime sleepiness, mean ± SD: G1: 10.84 ± 1.68 G2: 11.39 ± 2.34 G3: 11.96 ± 1.97 G4: 12.96 ± 1.97 p <0.001 Harms: NR Modifiers: NR C-67 Table C-1. Evidence table, continued Study Description Intervention Inclusion/ Exclusion Criteria/ Population Baseline Measures Outcomes Author: Dawson et al. 2012 31 Country: USA Intervention setting: NR Enrollment period: NR Funding: NR Author industry relationship disclosures: NR Design: RCT Note: See earlier study reporting on this population 32 in 2011 AHRQ review 9 Intervention: ESDM intervention for 2hours,twice a day, 5 days a week, for 2 years. Community intervention: Families were given resource manuals And reading materials at baseline and twice yearly Assessments: ADI-R, ADOS, MSEL, Vineland Scales of Adaptive Behavior, PDD Behavioral Inventory, EEG Groups: G1: ESDM G2: Community intervention Provider: Trained therapists Treatment manual followed: Yes Defined protocol followed: Yes Measure of treatment fidelity reported: Yes Co-interventions held stable during treatment: NR Inclusion criteria: • age <30 months at entry, • meeting criteria for an autistic disorder on the Toddler Autism Diagnostic Interview (ADI) and for autism or ASD on the Autism Diagnostic Observation Schedule(ADOS) and a clinical diagnosis based on DSM-IV criteria • residing within 30 minutes of the University of Washington. Exclusion criteria: • neurologic disorder of known genetic etiology, • significant sensory or motor impairment, major physical problems, seizures at the time of entry, • use of psychoactive medications, • a history of a serious head injury and/ or neurologic disease, alcohol or drug exposure during the MSEL Verbal IQ G1: 45.3, ± 17.5; G2: 48.1, ± 21.2 MSEL Nonverbal IQ G1: 83.6, ± 13.3 G2: 79.2, ± 11.3 Verbal IQ G1: 95.1, ± 15.7 G2: 75.1, ± 18.4 (p=0.004) Nonverbal IQ: G1: 93.1, ± 16.5 G2: 80.0, ± 15.8 (p=0.04) Vineland Communication G1: 95.3 ± 15 G2: mean76.1, ± 14.7 (p=0.02) Social G1: 74.7,± 10.0 G2: 66.5 ± 8.3 (p=0.02) Daily Living Skills G1: 72 ± 11.9 G2: 58.9 ± 7.9 (p=0.006), Aberrant Behaviors G1: 76.9, ± 13.6 G2: 61.2, ± 7.9 (p=0.001) PDD-BI Expressive Social Communication composite scores: G1: 65.4, ± SD 6.5; G2: 54.5, ± SD10.2; (p=0.004) C-68 Concomitant therapies, n (%): NR N at enrollment: G1: 17 G2: 14 N at follow-up: G1: 17 G2: 14 prenatal period • -nonverbal IQ below 35 Age, mean/yrs (range): G1: 54.1 months ± 4.9 months; G2: 54.1 months, ± 7.8 months Mental age, mean/yrs (range): NR Sex: Male to female ratio: G1+G2: 3.5:1 Race/ethnicity, n (%): G1+G2 : Asian 12.5%, white (72.9%), Latino (12.5%), and multiracial 14.6%) SES: NR Diagnostic approach: In Study Diagnostic tool/method: ADI, ADOS, DSM-IV Diagnostic category, n (%): Autism : 100% Other characteristics, n (%): ADOS Social scores: G1: 10.3, SD 2.3 G2: